The Covid-19 pandemic has transformed the way we think of diagnostics in our daily lives. In a recent webinar, BD Vice President for Diagnostics Nikos Pavlidis spoke with a clinician and an epidemiologist where they shared their perspectives on how testing developments have changed the way we track respiratory illnesses.
The point of care diagnostics and testing market has climbed dramatically with the rise of the Covid-19 public health crisis. We're seeking applications for diagnostics startups who would like to take part in INVEST Pitch Perfect Diagnostics 2.0 track at the conference, scheduled to take place March 28-30 in Chicago.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Reflecting on lessons learned from the pandemic, healthcare leaders pointed to the lack of coordination and glaring health disparities that hampered the U.S. pandemic response. Going forward, they hope to see future change in the healthcare system.
The Austin-based startup has distributed more than 500,000 Covid-19 test kits to date, and expects total sales to quadruple by the end of the year.
CVS Health named a new CEO in its earnings call on Friday. Between plans to further integrate its pharmacy and insurance businesses, and discussion about how a Covid-19 vaccine would be distributed, here are four other things the company is preparing for in the coming months.
CVS Health plans to add rapid Covid-19 tests at 1,000 locations by the end of the year. The company has not specified which rapid tests it will offer.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Starting in January, Medicare will pay $75 for tests that take longer than two days to deliver results. It currently pays $100 for each high-throughput Covid-19 test.
Google’s sister company launched a program in California and other states to help route patients to nearby coronavirus testing. Dr. Vivian Lee, president of health platforms for Verily, shared lessons learned from that effort and Verily’s work with schools and businesses.
Slovenski, who helped create the idea for Walmart’s health centers, left the company in August to join testing startup BioIQ. He shares how he built Walmart’s new health strategy from the ground up and what’s next at his new role.
The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics. Now, startups are once again trying their hand at selling test kits.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
At 21 drive-thru sites, anyone can now provide a sample by swishing a cotton swab around their mouths, putting it in a tube and dropping it in a receptacle on their way out — all within the comfort of their cars.
The two pharmacy chains plan to ramp up testing locations, with CVS saying it will add 1,000 sites and Walgreens saying it will add drive-thru testing in all 49 states. Currently, they have just a handful of sites across the U.S.
Two surveys released on Thursday showed many physicians don’t feel like they have adequate access to testing and medical supplies. A survey of more than 2,600 U.S. physicians showed the vast majority — 73 percent — said they were not able to test patients quickly and easily.
The Food and Drug Administration updated its guidance to note that it has not approved any at-home tests for Covid-19. A number of startups began offering private tests, for a cost, after a public shortage of testing has left many with symptoms searching for solutions.
After declaring a state of emergency on Friday, Trump announced that Google would be building a website that could route users to drive-thru testing sites for COVID-19. Alphabet’s subsidiary, Verily, said the tool was in the early stages of development, and that it planned to roll out testing in the Bay Area.